Chemical Innovations for Cardiovascular Therapeutics
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 1745
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Molecules Special Issue addresses a critical unmet need in cardiovascular medicine: the chemical innovation gap in developing next-generation therapies. While cardiovascular diseases (CVDs) remain the leading global cause of mortality, recent breakthroughs in medicinal chemistry, targeted delivery systems, and molecular profiling technologies now enable unprecedented precision in CVD drug design.
We specifically seek contributions that highlight:
- Novel chemical entities with validated cardiovascular targets (e.g., small molecules, RNA therapeutics, exosome modulators)
- Cutting-edge drug design strategies (AI-assisted molecular modeling, genoproteomic-guided discovery)
- Chemically-engineered delivery systems (nanocarriers, bioresponsive formulations)
- Molecular mechanisms with structural insights (X-ray crystallography, cryo-EM of drug-target complexes)
Why This Issue is Special:
- Chemical Focus: Unlike clinical pharmacology journals, we prioritize studies elucidating structure-activity relationships and molecular optimization of CVD agents
- Timeliness: Covers emerging chemical modalities (RNA drugs, exosome engineering) beyond traditional small molecules
Topics of Interest:
- Rational design of macrophage-targeting agents
- Chemical modulation of mitochondrial-cardiac interactions
- Structural basis of RNA drug delivery for CVD
- Synthetic approaches to exosome functionalization
Dr. Zia Shariat-Madar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- CVD
- drug therapy
- therapy targets
- inflammation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
